Satellos Bioscience Inc (MSCL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | |
| Cost of Goods | 38 |
| Gross Profit | -38 |
| Operating Expenses | 1,119 |
| Operating Income | -1,157 |
| Interest Expense | 18 |
| Other Income | -63 |
| Pre-tax Income | -1,238 |
| Net Income Continuous | -1,238 |
| Net Income | $-1,238 |
| EPS Basic Total Ops | -0.45 |
| EPS Diluted Total Ops | -0.45 |
| EBITDA(a) | $-1,220 |